Enzene Biosciences Ltd.
Clinical trials sponsored by Enzene Biosciences Ltd., explained in plain language.
-
New bone drug aims to match leading treatment for postmenopausal women
Disease control CompletedThis study tested whether a new drug called ENZ215 works as well as the approved drug Prolia for treating osteoporosis in postmenopausal women. It involved 504 women who received injections of either drug and were monitored for 12 months. The main goal was to see if the new drug …
Phase: PHASE3 • Sponsor: Enzene Biosciences Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
Scientists test copycat bone drug on healthy men
Knowledge-focused CompletedThis study aimed to see if a new version of the drug denosumab (called ENZ215) works the same way in the body as the versions already sold in Europe and the US. It involved 207 healthy adult men who received a single injection. Researchers tracked the drug levels in their blood a…
Phase: PHASE1 • Sponsor: Enzene Biosciences Ltd. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC